04 August 2003
Novel Cancer Vaccine to be Manufactured from Live Bacterium
29 May 2003
Placing and Open Offer of 6,500,000 new Ordinary Shares of 10p each at 80p per share.
29 May 2003
Interim Results for the six months ended 31 March 2003
For further information, please contact:
Julian Hanak
Commercial Services
Tel: +44 (0) 1782 714 181